Skip to main content
Clinical Trials/NCT03590678
NCT03590678
Completed
Not Applicable

Prospective Collection of Whole Blood Specimens in Pregnant Women

Illumina, Inc.16 sites in 6 countries3,000 target enrollmentFebruary 13, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy Related
Sponsor
Illumina, Inc.
Enrollment
3000
Locations
16
Primary Endpoint
Collect Whole Blood Specimens in Pregnant Women
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To prospectively collect whole blood specimens and clinical data from pregnant women scheduled for an invasive prenatal diagnostic procedure ("invasive procedure"). Specimens will be used for future testing with an investigational NIPT.

Detailed Description

This is a prospective multicenter study in which whole blood specimens will be collected from pregnant women scheduled for an invasive procedure. After the standard-of-care invasive procedure is performed in accordance with the site's clinical procedures, invasive prenatal diagnostic procedure results will also be collected.

Registry
clinicaltrials.gov
Start Date
February 13, 2017
End Date
December 31, 2019
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Be 18 years of age or older at enrollment,
  • Has a viable pregnancy (with documented fetal heartbeat) of at least 10 weeks, 0 days gestation at the time of maternal specimen collection,
  • Be scheduled for an invasive prenatal diagnostic procedure (either chorionic villus sampling \[CVS\], amniocentesis, or percutaneous umbilical cord blood sampling \[cordocentesis\]) for cytogenetic analysis of the fetus

Exclusion Criteria

  • Has a known maternal chromosomal anomaly,
  • Had an invasive prenatal diagnostic procedure in the current pregnancy before maternal specimen collection
  • Has a history of transplant or malignancy, or
  • Had a transfusion of blood or blood components up to 8 weeks before maternal whole blood specimen collection
  • Already participated in this study (enrolled previously).

Outcomes

Primary Outcomes

Collect Whole Blood Specimens in Pregnant Women

Time Frame: 3 years

To collect maternal whole blood specimens from approximately 5,150 women with corresponding cytogenetic results from invasive prenatal diagnostic procedures (performed per the standard of care) to achieve sample size goals

Study Sites (16)

Loading locations...

Similar Trials